Oxybenzone (二苯酮-3、羟苯甲酮)
Oxybenzone (二苯酮-3、羟苯甲酮 in Chinese) — official NMPA IECIC Chinese name, 2026 bulk supply lead-time/shortage status, formulation use levels, EU CosIng limits and product examples.
Oxybenzone (Official INCI: Benzophenone-3 · Official Name in Chinese / NMPA IECIC: 二苯酮-3、羟苯甲酮) is a tracked cosmetic ingredient in the Cosradar global formulation database. As of Q4 2026, global bulk supply shows no active stockout or force-majeure shortage (standard lead time: 2–4 weeks), with 0 cumulative launch & trade mentions and strong commercial adoption in Airless bottle / hydrogel patch & mask / BFS single-dose pod.
| Specification Dimension | Oxybenzone 2026 Formulation & Sourcing Benchmark | Compliance & Audit Verification |
|---|---|---|
| Official Name in Chinese (IECIC) | 二苯酮-3、羟苯甲酮 | China NMPA IECIC (2021) mandatory label translation |
| International INCI Name | Benzophenone-3 | Aligned with EU CosIng & US PCPC dictionary |
| Typical Use Level & pH Window | Use level: 0.5% – 3.0% · Optimal pH: pH 5.0 – 6.8 | 28-day thermal cycling (45°C / -15°C) & ISO 11930 QC |
| Primary Delivery Formats | Airless bottle / hydrogel patch & mask / BFS single-dose pod | Turnkey OEM sampling available (ISO 22716 / FDA OTC) |
| 2026 Supply & Lead-Time Status | Stable (2–4 weeks lead time) · Multi-origin backup ready | EU Reg 1223/2009 CosIng · US FDA MoCRA · China NMPA IECIC (2021) |
INCI, Chinese Name (IECIC) & Supply Status
Standard INCI, Chinese Name (IECIC) & Supply Status
INCI：Benzophenone-3
Official Name in Chinese (NMPA IECIC): 二苯酮-3、羟苯甲酮
Also called: benzophenone-3, BP-3, BZ-3
2026 Supply & Lead-Time Status: No force majeure / active stockout — 2–4 wk standard lead time (Backup OEM formulations available)
Mentions in launches & trade news
0
Related regulation
🇰🇷 Korea requires a warning statement above 2.4% benzophenone-3 (oxybenzone)
What happens · what to do
Under Ministry of Food and Drug Safety (MFDS) Notice No. 2026-56. In the same amendment, leave-on hair products are exempted from 'rinse off'-type warning statements. A six-month transition period applies to packaging materials.
What to do: Check the concentration and labelling of sunscreens and colour cosmetics containing benzophenone-3.
Source: MFDS 고시 제2026-56호 · reviewed 22 Sep
🇮🇩 Indonesia BPOM cosmetic ingredient rules: transition period ends
What happens · what to do
Under Regulation No. 25/2025 of the Indonesian Food and Drug Authority (BPOM): 101 substances are newly prohibited (including Quaternium-15, D4, 2-chloroacetamide and chlorophene); homosalate is restricted to face products (excluding sprays); and benzophenone-3 is restricted by product category. Products containing newly prohibited substances may not be renewed or sold.
What to do: Products on sale in, or being notified for, Indonesia should be checked against the new lists immediately; products that exceed the limits must be reformulated and re-notified.
Source: PerBPOM 25/2025
Active Ingredient Supply-Chain & Bilingual INCI Lookup
| INCI Name | Official Name in Chinese (NMPA IECIC) | 2026 Supply Disruption, Stockout & Lead-Time Status | US FDA / EU CosIng Limit & Turnkey OEM Formats |
|---|---|---|---|
| Bakuchiol | 补骨脂酚 (Bǔ Gǔ Zhī Fēn) | ⚠️ Botanical seed-extracted grade (≥99%): 4–6 wk lead time (seasonal crop price fluctuations). Bio-fermented grade: No stockout / 2-wk lead time. | Clean retinol alternative; no EU Annex III cap. Top formats: Unit-dose barrier serum pods & hydrogel eye masks. |
| Colloidal Oatmeal | 胶体燕麦 / 燕麦 (AVENA SATIVA) 仁粉 | ✅ Stable supply (2–3 wk lead time); zero force majeure alerts. Ultra-fine USP grade requires verified beta-glucan COA. | US FDA OTC Skin Protectant Monograph active. Top formats: Soothing hydrocolloid barrier patches & single-serve cream pods. |
| Alpha-Arbutin | α-熊果苷 (Alpha-Xióng Guǒ Gān) | ⚠️ High demand ahead of EU reformulation deadlines (3–4 wk lead time); requires Hydroquinone impurity < 10 ppm. | EU CosIng Annex III limit: ≤ 2.0% face cream, ≤ 0.5% body lotion. Top format: Light-shielded single-dose brightening ampoules. |
| Salicylic Acid | 水杨酸 (Shuǐ Yáng Suān) | ✅ Ample global capacity (2 wk lead time); encapsulated & micronized patch-grade demand up +65% YoY. | US FDA OTC Acne Monograph (0.5%–2.0%); EU Annex III ≤ 2.0%. Top format: OTC hydrocolloid & microneedle acne patches. |
| Sodium DNA (PDRN) | DNA 钠 (DNA Nà) | 🔥 Tight lead time on pharmaceutical salmon-trout grade (5–7 wks); vegan ginseng/microalgae PDRN scaling rapidly. | K-Beauty Olive Young #1 surge ingredient. Top format: Dissolving microneedle patches & sterile BFS unit-dose vials. |
Pick your category — get recalls & regulation alerts weekly
Leave your email and the category you make: each week we tell you what was recalled or noticed in the EU and US, which deadlines are close, and who just raised money. Or use RSS. Free; unsubscribe anytime.
- EU recalls and US Prop 65 notices in your category
- Upcoming regulatory deadlines
- Opportunities filtered for your role